Markets closed

GSK plc American Depositary Shares (Each representing two Ordinary Shares)

GSK · NYSE

Sep 2026upcoming

Next quarter

Expected to report Oct 28, 2026 — estimated from last year’s reporting date.

Consensus is $1.46 EPS for Sep 2026 across 5 estimates, ranging $1.37 to $1.52.

GSK Jun 2026

Reported Jul 28, 2026

: 7.09%
: -0.91%

: $1.27
: $1.36
: —
: —

Our read on this quarter has not been written yet. The filed figures and the source documents are above and below.

Symbol: GSK
Type: Stock
Sector: Health Care
Industry: Biotechnology: Pharmaceutical Preparations
Country: Europe
Exchange: NYSE

GSK is a global biopharma company with a purpose to unite science, technology, and talent to get ahead of disease together.

Key Issues

Bullish view

The Relation Therapeutics collaboration applies artificial intelligence to drug discovery and is intended to strengthen GSK’s early-stage pipeline, potentially improving research productivity.

Bearish view

The agreement concerns an early-stage pipeline, and the supplied evidence gives no clinical, regulatory, or financial proof that the collaboration will produce successful medicines.